Pancreatic stellate cell activation markers

Pancreatic stellate cell (PSC) activation markers are a collection of proteins and cellular changes that signify the transition of quiescent PSCs into an activated, myofibroblast-like state (Apte et al., 1998). In the healthy pancreas, quiescent PSCs are characterized by the storage of vitamin A in lipid droplets and the expression of markers such as glial fibrillary acidic protein (GFAP) and desmin (Bachem et al., 1998). Upon pancreatic injury or the onset of inflammation, these cells undergo a dramatic phenotypic shift, losing their retinoid stores and upregulating activation markers including alpha-smooth muscle actin (alpha-SMA), collagen type I, and fibronectin (Vonlaufen et al., 2007). This activation process is the primary driver of pancreatic fibrosis, contributing to the dense, collagen-rich stroma observed in chronic pancreatitis and pancreatic ductal adenocarcinoma (PDAC) (Erkan et al., 2012). While these markers are used as diagnostic and prognostic indicators of fibrotic progression, the signaling pathways that regulate them—such as the TGF-beta, PDGF, and Hedgehog pathways—are significant targets for therapeutic intervention. Drugs like pirfenidone and nintedanib are being investigated for their ability to modulate these markers, thereby reducing the fibrotic barrier and potentially improving the delivery of chemotherapeutic agents to pancreatic tumors.

Other names

PSC activation markersPancreatic fibrosis markersActivated pancreatic stellate cell markersFibrosis/activation markers in PSCs

Inhibition of pro-fibrotic signaling pathways (such as TGF-beta and PDGF), suppression of myofibroblast differentiation, and reduction of extracellular matrix protein synthesis.